Skip to main content
. 2021 Nov 10;9(1):e1109. doi: 10.1212/NXI.0000000000001109

Figure 2. Relative Change in Serum Anti-MAG IgM Titers or Levels and Response to Immunotherapies in Patients With Anti-MAG Neuropathy.

Figure 2

An overview of the studies that assessed the relative change in anti-MAG IgM autoantibodies (pretreatment and posttreatment) and clinical response to immunotherapies. (A) Relative change in anti-MAG IgM titers in the responder (a) and the nonresponder group (b); (B) Relative change in paraprotein levels in the responder and the nonresponder group; and (C) Relative change in total IgM levels in the responder and the nonresponder group. Data are indicated as mean values and the circle size represents comparative size of the study (number of participants). MAG = myelin‐associated glycoprotein.